ArticleHuman vaccines & immunotherapeutics2021

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.

Felicia Scaggs Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.